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its presence in intraneuronal neurofibrillary tangle deposits, where it takes the form of aggregated paired helical and straight
filaments. Although the precise mechanisms by which tau contributes to neurodegeneration remain unclear, tau aggregation
is commonly considered to be a critical component of tau-mediated pathogenicity. Nevertheless, the context in which tau aggre-
gation begins in vivo is unknown. Tau is enriched in membrane-rich neuronal structures such as axons and growth cones, and
can interact with membranes both via intermediary proteins and directly via its microtubule-binding domain (MBD). Membranes
efficiently facilitate tau aggregation in vitro, and may therefore provide a physiologically relevant context for nucleating tau
aggregation in vivo. Furthermore, tau-membrane interactions may potentially play a role in tau’s poorly understood normal phys-
iological functions. Despite the potential importance of direct tau-membrane interactions for tau pathology and physiology, the
structural mechanisms that underlie such interactions remain to be elucidated. Here, we employ electron spin resonance spec-
troscopy to investigate the secondary and long-range structural properties of the MBD of three-repeat tau isoforms when bound
to lipid vesicles and membranemimetics. We show that the membrane interactions of the tau MBD are mediated by short amphi-
pathic helices formed within each of the MBD repeats in the membrane-bound state. To our knowledge, this is the first detailed
elucidation of helical tau structure in the context of intact lipid bilayers. We further show, for the first time (to our knowledge),
that these individual helical regions behave as independent membrane-binding sites linked by flexible connecting regions. These
results represent the first (to our knowledge) detailed structural view of membrane-bound tau and provide insights into potential
mechanisms for membrane-mediated tau aggregation. Furthermore, the results may have implications for the structural basis of
tau-microtubule interactions and microtubule-mediated tau aggregation.INTRODUCTIONTau was originally identified as a microtubule-associated
protein and shown to influence microtubule dynamics,
reduce microtubule treadmilling, and stabilize microtubule
structure and organization (1,2). In the human central ner-
vous system, tau is found as six different isoforms that are
generated by the alternative splicing of three exons (3,4).
The longest human tau isoform, commonly referred to as
htau40, contains all three alternative exons, whereas the
shortest isoform, commonly referred to as tau352, contains
none of the three (Fig. 1). Two of the exons code for protein
sequences in the N-terminal projection domain of tau,
whereas the third exon (exon 10) codes for an alternative
additional repeat (R2) in the tandem repeat containing
the microtubule-binding C-terminal domain of tau, which
always contains the three other repeats (R1, R3, and R4).
Tau is the principal protein component of the neurofibrillary
tangle deposits that constitute one of two pathological hall-
marks of Alzheimer’s disease (AD) (5–8). Within the intra-
neuronal tangle deposits, tau is found in an aggregated
filamentous form that can assume various morphologies,Submitted May 16, 2014, and accepted for publication July 24, 2014.
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0006-3495/14/09/1441/12 $2.00including paired helical filaments (PHFs) and straight fila-
ments (SFs), as well as ribbons and sheets. Whereas the fa-
milial forms of AD involve mutations in genes involved in
the production of the amyloid-beta (Ab) peptide, mutations
in tau cause frontotemporal dementia (9–11), the second
most common form of dementia after AD. Disease-linked
alterations in the human tau gene MAPT lead either to
mutant forms of tau protein or to changes in tau splicing
that typically favor the formation of R2-containing four-
repeat (4R) forms of the protein.
The precise mechanisms by which tau leads to neurode-
generation in frontotemporal dementia, and presumably
in AD as well, remain unclear, but tau assembly and
aggregation into PHFs and other filamentous species are
commonly considered to play a key role. Although tau
can be induced to aggregate in vitro in a number of
ways, the context for the nucleation of tau aggregation
in vivo is not known. Because lipid membranes are known
to enhance tau aggregation in vitro (12–15) and tau has
been reported to interact both indirectly and directly
with cellular membranes (16–20), membrane surfaces
may provide an effective locus for tau aggregation
in vivo. This conjecture is supported by observations of
membrane-associated tau filaments in tissues from ADhttp://dx.doi.org/10.1016/j.bpj.2014.07.046
FIGURE 1 Cartoon representation of FL tau protein. Tau possesses a
multidomain architecture that encompasses alternatively spliced exons
(2,3,10), two proline-rich domains (P1 and P2), MBD repeats (R1–R4),
and the pseudorepeat R0. The amino acid sequences of the tau MBD repeats
are shown, each on a separate line. The alternatively spliced R2 repeat is
shown in gray. The tau fragment K19 used in these studies includes repeats
R1, R3, and R4 plus four C-terminal flanking residues (KKIE). The PHF6*
and PHF6 hexapeptide aggregation-nucleating motifs are underlined in R2
and R3, respectively.
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brane-mediated tau aggregation, little is known about
the structural consequences of tau membrane binding or
how membrane binding may enhance tau aggregation.
Here, we use electron spin resonance (ESR) spectroscopy
to explore the conformations of regions within the tau
microtubule-binding domain (MBD) in the context of a
membrane-bound tau MBD fragment as well as a full-
length (FL) human tau isoform. We find that within each
repeat, a short segment that was previously identified as
exhibiting a weak preference for helical structures adopts
a fully helical amphipathic structure. Thus, tau-membrane
interactions are mediated by short amphipathic helices.
We show that the helices are located at the surface of
the membrane and do not penetrate deeply into the hy-
drophobic membrane interior. Distance measurements
between helical segments located in different repeats indi-
cate that the individual helices behave independently of
one another and that the intervening regions likely behave
as highly dynamic and flexible linkers. The implications
for tau structure and membrane-induced tau aggregation
are discussed.MATERIALS AND METHODS
Protein mutagenesis, expression, and
purification
Double and single tau mutants were produced using a site-directed muta-
genesis kit (Agilent Technologies, Santa Clara, CA) as directed by the
manufacturer. Recombinant proteins were expressed in E. coli BL21/DE3
cells (Novagen, San Diego, CA) transfected with plasmids encoding the
tau fragment K19 or the FL tau isoform tau352 under the control of a T7
promoter. The cells were lysed by sonication and lysates were cleared
from cell debris by ultracentrifugation at 150,000  g. Tau variants were
further purified by cation-exchange chromatography followed by reverse-
phase high-performance liquid chromatography on a C4 column (GRACE,
Columbia, MD). Protein purity was confirmed by SDS-PAGE. Purified
proteins were lyophilized and stored at 20C.Biophysical Journal 107(6) 1441–1452Preparation of lipid vesicles and membrane
mimetics
Lipids were purchased from Avanti Polar Lipids (Alabaster, AL). Deuter-
ated compounds were obtained from Cambridge Isotope Laboratories
(Tewksbury, MA). For continuous-wave (CW)-ESR measurements, ali-
quots of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and
1-palmitoyl-2-oleoyl-sn-glycero-3-(phospho-L-serine) (POPS) in chloro-
form were mixed in proportions to yield a final 1:1 molar ratio of non-
charged/charged lipids. A separate sample of the same molar proportion
of POPC and POPS plus spin-labeled lipid 1-palmitoyl-2-stearoyl-(5-
doxyl)-sn-glycero-3-phosphocholine (16:0-5 Doxyl PC or 5PC) added to
a 1:690 nonlabeled/labeled lipids molar ratio was prepared. The chloroform
mixtures were dried under nitrogen gas and then kept under vacuum for at
least 4 h. Dried lipids were dissolved in 10 mMNaH2PO4, 10 mMNaCl pH
7.4. Small unilamellar vesicles (liposomes) of 1:1 POPC/POPS were pre-
pared by repeated sonication. To remove large multilamellar vesicles and
titanium particles, the ready liposome solutions were centrifuged at
3000  g for 30 min at room temperature. Throughout all experiments,
only freshly made liposomes were used. The typical vesicle diameters
were ~75 nm as determined by dynamic light scattering (not shown). Mem-
brane-mimetic micelles composed of lyso-1-palmitoyl-phosphatidylgly-
cerol (LPPG) were prepared at a concentration of 40 mM. Spheroidal or
rod-like SDS micelles were prepared using SDS-d25 at concentrations of
40 or 450 mM, respectively.ESR sample preparation
Nitroxide spin-labeled proteins were produced by dissolving K19 and
tau352 cysteine mutants in buffer, adding S-(2,2,5,5-tetramethyl-2,5-dihy-
dro-1H-pyrrol-3-yl)methyl methanesulfonothioate (MTSSL; Toronto
Research Chemicals, Toronto, Canada) to a 30:1 MTSSL/protein molar ra-
tio, and agitating for 2 hr at room temperature. Excess spin label was
removed using Micro Bio-Spin columns (Bio-Rad Laboratories, Hercules,
CA). Samples for CW-ESR experiments were prepared in NaH2PO4,
10 mMNaCl pH 7.4, and samples for distance measurements were prepared
in NaH2PO4, 100 mM NaCl using D2O instead of H2O, pD 7.4 (regular pH
reading without pD correction). Select duplicate distance measurements
carried out in the buffer used for CW-ESR experiments produced virtually
identical time-domain pulse-ESR dipolar spectroscopy (PDS) data and dis-
tance distributions. For membrane or membrane-mimetic-containing sam-
ples, singly and doubly spin-labeled cysteine mutants of K19 or tau352
were incubated with liposomes at molar ratios ranging from 1:1200
to 1:1600, to ensure close to 100% binding as confirmed by CW-ESR.
The final protein concentrations ranged from 40 mM to 52 mM. Doubly
spin-labeled cysteine mutants were mixed with membrane mimetics
in the following proportions: 60 mM (or 30 mM) protein/40 mM SDS,
100 mM protein/450 mM SDS, and 60 mM protein/40 mM LPPG.
All CW-ESR measurements on spin-labeled lipids and on spin-labeled
tau mutants bound to POPC/POPS liposomes or free in solution were per-
formed on a Bruker ELEXIS E500 (Bruker, Billerica) spectrometer equip-
ped with a Bruker ER 4122SHQE resonator. The spectra were recorded at
25C using a Bruker ER4131VT temperature controller. The full extent of
the nitroxide CW-ESR spectrum was recorded using an incident microwave
power of 1.26 mW, with a field modulation of 2.3 G for 5PC and lipid-
bound protein, and 1.2 G for free protein in solution. All samples for
CW-ESR measurements were placed into 50 mL precision microcapillaries
with sealed bottoms (Kimble Glass, Vineland, NJ).
Nitroxide spectrum microwave power saturation (23) was employed to
measure accessibility to the commonly used fast-relaxing agents oxygen
(O2) and Ni(II)-diammine-2,2’-(ethane-1,2-diyldiimino)diacetic acid com-
plex (NiEDDA). Measurements were performed on regular samples in the
presence of O2, deoxygenated and argon-filled samples, and deoxygenated
and argon-filled samples containing NiEDDA. Sample deoxygenation was
performed on a vacuum line by repeatedly bringing the capillary tube with
Tau Binds Membrane via Short Helices 1443the sample to a soft vacuum level and filling it with argon gas. Finally, the
capillary tube was filled with argon to ~0.9 bar and flame sealed. In all
cases, the sample volume was ~6.7 mL (i.e., 10 mm capillary length).
The final concentration of NiEDDA was 5 mM, and that for O2 was ob-
tained by equilibration in air at 25C. To obtain the half-saturation param-
eter, P1/2 (23,24), the central line in the nitroxide CW-ESR spectrum (~20 G
width for lipid samples and ~8 G for protein without lipid) was recorded as
a function of the microwave power (varied from 0.5 mW to 200 mW in 20
steps; see Fig. S1 in the SupportingMaterial). The measured intensity of the
central line was plotted as a function of the square root of the microwave















where P is the microwave power applied and ε is a line-homogeneity
parameter. We obtained the best fits using ε ¼ 1.5 (which is typical of a
highly homogeneous spectrum).
In the calculations of the accessibility parameter, P, for both O2
and NiEDDA, we used the data for K347C in deoxygenated solution as a
reference (Fig. S2 b). A soluble protein was used as such a reference in a
previous study on a membrane protein (25). Indeed, the reference used af-
fects the absolute accessibility values (vide infra), but the insertion depth
(or contrast) parameter, F, defined as a logarithm of the ratio of accessibil-
ities to O2 and NiEDDA (defined above) is, of course, reference invariant.









where DH (or DHref) is the line width and superscript ref indicates the refer-
ence. All analyses and fittings of CW-ESR power saturation data were per-formed in OriginLab software (OriginLab, Northampton, MA). To ensure
data reproducibility, the measurements were performed twice on all singly
labeled residues in helixes 3 and 4 in K19 and on 5PC-labeled samples.DEER distance measurements and distance
modeling
Distance measurements were performed on doubly spin-labeled tau mutants
free in solution (100 mM protein) and in the presence of spheroidal and rod-
like SDS micelles, LPPG micelles, and POPC/POPS liposomes. Glycerol-
d8 was added to 40% (w/v) to samples of protein in buffer and to 30% (w/v)
to samples of protein bound to SDS or LPPG. The liposome samples did not
contain glycerol. All samples for pulse-ESR measurements were placed
into custom-sized 1.8 mm i.d. borosilicate glass sample tubes (Wilmad-
LabGlass, Vineland, NJ) and plunge-frozen in LN2. All distance measu-
rements were performed at 60 K as previously described (26,27) using an
in-house-built Ku-band pulse ESR spectrometer (28) operating at 17.3
GHz. A standard four-pulse double electron-electron resonance (DEER)
sequence (29) with p/2-p-p pulse widths of 16 ns, 32 ns, and 32 ns, respec-
tively, and a 32 ns pump p pulse was used. The frequency separation be-
tween the detection and pump pulses was 70 MHz. The detection pulses
were positioned at the low-field edge of the nitroxide spectrum. The dipolar
evolution times ranged from 1.8 to 8.2 ms depending on the distance
measured and the spin-label phase relaxation time. The data recording
times were in the range of 2–16 h depending on the distance measured, sam-
ple composition, and protein concentration. The liposome samples usually
required 8–16 h and shorter times were used for other samples.
The background (baseline) was removed from raw time-domain sig-
nals, and distances were reconstructed from the baseline-corrected and
normalized signals using the Tikhonov regularization method (30) and
refined by the maximum-entropy method (31). In most cases, the back-
ground signal in the raw time-domain DEER data was removed by fitting
to a straight line in a semilogarithmic plot, i.e., to a homogeneous back-
ground. However, in the case of liposome samples, backgrounds deviatedslightly from a straight line and were fit using second-degree polynomials
(Fig. S3).
The experimental distance distributions were modeled by fitting them to
Gaussian functions in the OriginLab software. The quality of the fit param-
eter, R2, was in the range of 0.7–0.99, with R2> 0.9 being the case for more
than 90% of the fits.RESULTS
To characterize the structural properties of tau MBD of hu-
man tau protein bound to lipid membranes, we employed
site-directed spin labeling (SDSL) and ESR spectroscopy
(32), a method that can provide detailed information about
protein secondary and higher-order structure, aswell as report
on dynamics (23,24,26,27,32–43). Furthermore, ESR has
proven to be a powerful tool for structural studies of mem-
brane-bound intrinsically disordered proteins (26,27,44)
and their amyloid forms (45,46). We conducted experiments
using a tau fragment (K19) encompassing residues 244–274
and 306–372 of the longest human tau isoform, htau40.
K19 corresponds to the MBD repeats of the alternatively
spliced three-repeat (3R) forms of tau that contain repeats
R1, R3, and R4, whereas repeat R2 is spliced out (Fig. 1).
In addition, we also performed a subset of experiments using
the shortest FL tau isoform, tau352, to assess whether the
behavior of the K19 fragment mirrors that of the FL protein.
We employed CW-ESR microwave power-saturation experi-
ments (23–25) to obtain local structural information at the
single-residue level. PDS measurements based on DEER
spectroscopy (29,35,42,47) provided information regarding
the long-range tertiary organization of the tau MBD repeats
when bound to membrane vesicles and membrane mimetics.Tau K19 binds to unilamellar 1:1 POPC/POPS lipid
vesicles, and the segments comprising residues
253–261, 315–323, and 346–355 adopt a highly
helical structure
The tau MBD interacts directly with biological membranes
(16,19,20,48,49), and recent studies employing solution-
state NMR demonstrated that regions within tau K19
adopt a highly helical conformation upon interaction with
membrane-mimetic detergent and acidic lysophospholipid
micelles (50). Circular dichroism (CD) measurements sug-
gested that helical structure is also formed within K19 in
the presence of 1:1 POPA/POPC liposomes. Helical struc-
ture in the micelle-bound protein was localized to residues
253–261 (helix 1), 315–323 (helix 3), and 346–355 (helix
4), located within repeats 1, 3, and 4 of K19, respectively
(50), but whether these regions are helical in the vesicle-
bound state is not known.
To directly probe the conformation of these segments in
liposome-bound tau K19, we generated 27 single cysteine
mutants positioned at residues 252–261, 315–322, and
345–354 within the K19 fragment, as well as nine singleBiophysical Journal 107(6) 1441–1452
FIGURE 3 Complete set of CW-ESR spectra of lipid-bound tau. The
spectra from spin-labeled residues in R1/helix 1 of FL tau are plotted in
the leftmost column; all other spectra are from spin-labeled residues in
the tau K19 construct (residues from R1/helix 1, R3/helix 3, and R4/helix
4 are plotted in the second, third, and fourth columns as indicated). The
spectra were baseline corrected and normalized to the same number of
spins. The line from a Bruker standard is marked by the asterisk. To see
this figure in color, go online.
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shortest FL tau isoform, tau352. We labeled these tau vari-
ants with MTSSL and monitored binding to liposomes by
recording the MTSSL CW-ESR spectrum as a function of
the spin-label position in the protein polypeptide chain
in buffer solution and in the presence of POPC/POPS vesi-
cles at lipid/protein molar ratios of at least 1200:1, well
above values associated with lipid-induced tau aggregation
(13,51). To ensure complete binding, we used a higher
proportion of acidic phospholipid than is typically found
in biological membranes. At lower anionic lipid content,
tau membrane affinity is decreased, leading to a greater per-
centage of unbound protein at a given protein/lipid molar
ratio, but the helical character of the membrane-bound frac-
tion is preserved (50). Furthermore, in certain disease states,
including AD, anionic phospholipid content is increased in
cell membranes (52).
The nitroxide CW-ESR spectra for both K19 and FL tau
protein in the absence of lipids are characterized by narrow
peaks, indicating a highly mobile spin label (Fig. 2, green),
which is typical for nitroxide spin label attached to unstruc-
tured proteins, such as the previously characterized a-synu-
clein (53,54), or other unstructured protein segments (55).
These data are in agreement with NMR data indicating
that tau K19 and FL tau are highly dynamic and unstruc-
tured in solution (50,56–60).
Upon addition of liposomes composed of a 1:1 molar
ratio of noncharged/charged lipids (POPC/POPS), we ob-
served changes in the CW-ESR spectra for all studied tau
variants that indicate restricted spin-label mobility and
are characteristic of more constrained protein dynamics
(Fig. 2, black). Thus, these spectral changes provide evi-
dence for the interaction of tau K19 and tau352 with the
POPC/POPS liposomes. The CW-ESR spectra for all spin-
labeled liposome-bound tau variants are plotted in Fig. 3.
As shown in the figure, under our experimental conditions,
the tau MBD-lipid association is virtually complete. The
contribution from unbound protein or unreacted spin label
to the CW-ESR spectra is negligible (in some cases, it canFIGURE 2 Representative CW-ESR spectra of spin-labeled residues in
the MBD repeat region of tau (helices 1, 3, and 4). The spectra in solution
with no lipid are in green and the spectra of lipid-bound protein are in black.
The spectra in the left panel are from FL tau352 spin labeled at position 253
in R1/helix 1. The spectra in the middle and right panels are from the tau
K19 construct, spin labeled at positions 315 and 353 in R3/helix 3 and
R4/helix 4, respectively. A narrow peak marked by the asterisk in the right
panel is from a Bruker standard.
Biophysical Journal 107(6) 1441–1452be noticed as narrow lines of very low intensity superim-
posed on the spectrum from lipid-bound protein; Fig. 3).
To assess secondary structure at the spin-labeled sites of
membrane-bound tau, we conducted experiments to deter-
mine the accessibilities of the nitroxide spin label in each
of the tau variants to the fast-relaxing colliders O2, which
has high solubility in lipids (~21% at equilibrium with
air), and NiEDDA, which is polar and highly water soluble.
In these experiments, we estimated the microwave power
saturation effects on the central line in the nitroxide
CW-ESR spectrum produced by either O2 or NiEDDA
(Fig. S1). In principle, these data can be used to distinguish
solvent exposed from buried residues as well as to determine
the orientation of spin-labeled residues with respect to the
membrane surface (23,24,53,61,62). The determined acces-
sibilities to both O2 (P(O2)) and NiEDDA (P(NiEDDA))
are plotted in Fig. 4 a as a function of spin-label position
(residue number). A careful examination of these data
reveals an out-of-phase change in the accessibilities to O2
and NiEDDA with a periodicity of three or four residues
that is characteristic of a-helical structure.
The depth parameter F (F ¼ ln[P(O2)/P(NiEDDA)])
can be used to better visualize the difference between
FIGURE 4 (a) Dependence of the accessibility parameterP on the spin-
label position for all studied sites in helices 1, 3, and 4, located in repeats
R1, R3, and R4, respectively, of FL tau and tau K19. The data obtained
in air (P(O2)) and 5 mM NiEDDA (P(NiEDDA)) are shown by solid
and open circles, respectively, connected by black lines. (b) The depen-
dence of the depth parameter, F, on spin-label position for all studied sites
is shown in green squares connected by black lines. The experimental data
were fitted to a cosine function to examine periodicity in V (see Materials
and Methods); the fitted curves are shown in red and the resulting period-
icity, N, and quality of fit, R2, are indicated. In both a and b, the data for
helices 1, 3, and 4 in tau K19 are plotted in the upper plots and the data
for helix 1/FL are shown in the lower plot. The positions of original hydro-
phobic residues are labeled and designated by arrows. TheV parameter for
spin-labeled lipid, 5PC, is shown in the upper-right plot in magenta (value
of 1.78). Note that V scale for the 5PC sample, shown on a y axis on the
right side of the graph, is shifted down relative to that for tau mutants.
Tau Binds Membrane via Short Helices 1445P(O2) andP(NiEDDA), and consequently to assess protein
topology. Spin-labels attached to more solvent-exposed res-
idues, with smaller P(O2) and larger P(NiEDDA), have a
smaller F parameter and vice versa. The calculated values
of F for each of the studied residues in tau K19 and FL
tau352 are plotted versus residue number in Fig. 4 b (green
open squares connected by black lines). Within each of the
studied amino acid segments (252–261, 315–322, and 345–
354), F exhibits a clear periodic behavior. The data within
each separate segment were fit to a periodic function,
F(n) ¼ F0 þ Acos(2pn/N þ b) (53,62) (Fig. 4 b, redline), and the resulting values of the periodicity N ranged
between 3.4 and 3.8 amino acids per turn for the three indi-
vidual segments. The average value of 3.63 5 0.17 amino
acids per turn agrees well with the theoretical a-helical peri-
odicity of 3.6. A similar approach was used to analyze the
periodicity of liposome-bound a-synuclein (44,53).
A close inspection of the data plotted in Fig. 4 b shows
that spin labels positioned at sites of hydrophobic residues
(L253, V256, and I260 in helix 1; L315 and V318 in helix 3;
and F346, V351, and I354 in helix 4) have larger F-values
(indicating lesser/greater accessibility to NiEDDA/O2), con-
sistent with these positions being oriented toward the lipid
membrane. Sites of hydrophilic residues (N255 and S258
in helix 1; S316, T319, and S320 in helix 3; and D348
and S352 in helix 4) are characterized by smaller F-values,
consistent with greater solvent exposure. Interestingly, the
helical arrangement of amino acids in helix 1 shows a shift
of approximately one residue between the K19 fragment and
the FL tau352 protein (Fig. 4 b, upper and lower leftmost
panels). This might be a result of experimental uncertainty
or might result from the influence of regions of the FL pro-
tein that are not present in the K19 fragment. In either case,
the region in question clearly adopts an amphipathic helical
structure in both contexts.The helices in the tau MBD repeats are located
at the membrane surface and do not penetrate
deeply into the lipid bilayer
We noted that the entire set of CW-ESR nitroxide spectra
possess nearly identical line shapes (Fig. 3). This obser-
vation points to similar dynamic properties among all
spin-labeled residues. A coarse estimate of the dynamic
properties of a spin-labeled site can be obtained from the in-
verse width of the central line in the CW-ESR nitroxide
spectrum (DH0
1) (63). Values of DH0
1 for all recorded
CW-ESR spectra in both K19 and FL tau fall into a narrow
range of 0.3–0.37 Gauss1, which is considerably larger
than values typically observed for substantially immobilized
spin-labeled residues in transmembrane helices (61). The
observed values thus indicate a lack of significant spin-label
immobilization and therefore are consistent with the helical
segments being positioned on the membrane surface without
penetrating deeply into the bilayer. Similar behavior was
observed for spin-labeled residues in the membrane-bound
region of human a-synuclein (53).
The P(O2) data (Fig. 4 a) provide further support for the
conclusion that the tau K19 helices are positioned at the
membrane surface. The measured values for O2 accessi-
bility exhibit a relatively flat pattern that is only weakly sen-
sitive to the expected orientation of a given site toward the
membrane or the solvent. This suggests a similar level of
exposure to O2 for all sites, which is less consistent with
complete burial of membrane-facing sites in the spin label
in the O2-rich hydrocarbon region of the membrane, andBiophysical Journal 107(6) 1441–1452
1446 Georgieva et al.instead is more consistent with these sites being positioned
largely in the headgroup region of the membrane, which is
expected to have an O2 content that is more similar to that
present in the surrounding aqueous solvent (64).
To further assess the position of the K19 helices with
respect to the membrane, we measured the O2 and NiEEDA
accessibilities and determined the F parameter of a spin-
labeled lipid 5PC (16:0-5 Doxyl PC) incorporated into lipo-
somes of 1:1 POPC/POPS under the same conditions used
for the spin-labeled tau mutants. We then compared the
results with those obtained for spin-labeled sites in tau
K19. 5PC is a well-characterized standard for estimating
membrane immersion depth, with a paramagnetic nitroxide
placed at the interface between the polar headgroup and hy-
drophobic acyl chain regions (65). Therefore, F-values that
are either larger or smaller than those for 5PC should specify
either deeper penetration in the lipid acyl chain region or a
position closer to the membrane surface, respectively. Our
results show that O2 had a pronounced effect on the micro-
wave power saturation properties of 5PC spectrum, whereas
the effect of 5 mM NiEDDAwas marginal (Fig. S2 a). Thus,
under our experimental conditions, 5PC was almost inacces-
sible to the hydrophilic relaxer, NiEDDA. This is dissimilar
to our data for all spin-labeled tau mutants, since for each
of them the microwave power saturation was affected by
both O2 and NiEDDA, although the extent depended on
the spin-label position (Fig. S2 c). Furthermore, for 5PC,
we obtained a F parameter of 1.78, whereas the F-values
for tau mutants were typically smaller, with some being
close to zero (Fig. 4 b). These observations confirm that
the helices in membrane-bound tau MBD are associated
with the membrane periphery, in agreement with a previous
analysis of micelle-bound K19 using NMR (50).Long-range architecture of membrane-bound
tau MBD: independent helices separated by
flexible linkers
To evaluate the long-range architecture of tau K19 on the
membrane surface and, in particular, the relative arrangement
of the individual helices described above, we conducted
DEER distance measurements on doubly spin-labeled
cysteine mutants of the K19 fragment. We designed seven
mutants with cysteines located either in the individual helices
or in the intervening linker regions (linker 1 refers to the
region between helix 1 and helix 3, and linker 2 refers to the
region between helix 3 and helix 4).We used these seven pairs
to evaluate distances between the following locations: helix
1/linker 1 (S258C/G273C), helix 1/helix 3 (S258C/S320C),
helix 1/helix 4 (S258C/S352C), linker 1/helix 3 (G273C/
S320C), helix 3/linker 2 (S320C/G335C), helix 3/helix 4
(S320C/S352C), and linker 2/helix 4 (G335C/S352C). After
spin labeling with MTSSL, we subjected these K19 variants
to PDS distance measurements both in the free state (no lipid
present) and in the presence of 1:1 POPC/POPS liposomes asBiophysical Journal 107(6) 1441–1452well as several membrane mimetics (spheroidal LPPG
micelles (40 mM LPPG) and spheroidal and cylindrical
(rod-like) SDS micelles (40 or 450 mM SDS, respectively)).
We evaluated whether any protein aggregation occurs in
the absence or presence of membranes by comparing the
experimental modulation depth (66) with a known value
for the same experimental conditions (37,67). Under our
experimental conditions, the previously determined modu-
lation depth for doubly spin-labeled proteins is 0.23
(37,67). Smaller values most likely indicate low spin-label-
ing efficiency (37), whereas larger values point to a larger
number of interacting spins (68) than two and consequently
to protein aggregation. The modulation depths in our exper-
imental DEER data for the various double spin-labeled K19
mutants were equal or very close to 0.23 (Fig. 5), strongly
suggesting that the polypeptides remain monomeric. In
addition, magnetic dilution experiments in which cysteine-
free unlabeled protein was added to samples containing
spin-labeled protein showed no alterations in the DEER
signal and reconstructed distances, indicating that the dis-
tance distributions originate from intramolecular contri-
butions, and largely excluding any possible presence of or
contribution from protein aggregates in these measurements
(Figs. S4 and S5).
We fit the experimental DEER-derived distance distribu-
tions by using Gaussian functions to estimate both the
average distance and distance distribution width (Fig. 5).
In all cases, a single Gaussian provided a satisfactory repre-
sentation of the experimental data. In the case of the S258C/
S352C (helix 1/helix 4) double mutant in the presence of
lipid vesicles, we were unable to record a distance due to
an apparently very long (exceeding 6 nm) interspin distance,
since short phase relaxation times precluded measurement of
the DEER signal out to the long dipole evolution times
required for such distance. The averaged distance and dis-
tance distribution, characterized by Gaussian mean and full
width at half-maximum (FWHM, Dr), varied depending on
the spin-label location (Table 1). Generally, the distributions
were considerably broader (in some cases as wide as 3 nm)
than those observed in well-structured proteins in solution
(43,67,69) and instead were consistent with the distributions
typically observed for highly unstructured proteins (27).
The dependence of the measured distances on the
different conditions examined generally falls into two cate-
gories depending on whether both of the spin labels were
located in a helical segment or one of the labels was located
in a linker region. Helix-to-linker distances were found to be
relatively independent of whether the sample contained
lipid vesicles or membrane mimetics, with a value of
~3 nm observed in all cases (average difference between
LPPG micelle and POPC/POPS vesicle data of 0.4 nm
with a standard deviation (SD) of 0.4, paired t-test, p ¼
0.15). In contrast, helix-to-helix distances were found to
be dependent on the presence and type of membrane or
membrane mimetic (average difference between LPPG
FIGURE 5 Experimental time-domain DEER data (left side of each panel) and reconstructed distance distributions for doubly spin-labeled cysteine mu-
tants in seven K19 tau constructs (S258C/G273C, S258C/S320C, S258C/S352C, G273C/S320C, S320C/G335C, S320C/S352C, and G335C/S352C). The
data for buffer, micelles of 40 mM SDS, micelles of 450 mM SDS, micelles of 40 mM LPPG, and equimolar POPC/POPS liposomes are shown in black,
blue, green, orange, and red, respectively. The experimentally obtained distance distributions were modeled by fitting them to Gaussian functions, with the
fits shown in violet. Distances obtained from the fits are listed in Table 1.
Tau Binds Membrane via Short Helices 1447micelle and POPC/POPS vesicle data, using an estimate of
8 nm for the helix 1/helix 4 distance on vesicles, of 2.5 nm
with an SD of 0.4, paired t-test, p ¼ 0.009). In general, the
shortest helix-to-helix distances were observed in the pres-
ence of 40 mM LPPG, with longer distances observed inthe absence of any lipid or membrane mimetic, even longer
distances observed in the presence of either 40 or 450 mM
SDS, and the longest distances observed in the presence
of POPC/POPS vesicles. This dependence suggests that
the confinement of the membrane-binding helices to theBiophysical Journal 107(6) 1441–1452
TABLE 1 Mean distances, r, and widths, Dr, derived from Gaussian function fits of the experimentally obtained interspin distance
distributions for doubly spin-labeled cysteine mutants in tau K19
Conditions
r5 Dr/2
S258C/G273C S258C/S320C S258C/S352C G273C/S320C S320C/G335C S320C/S352C G335C/S352C
helix 1/linker 1 helix 1/helix 3 helix 1/helix 4 linker 1/helix 3 helix 3/linker 2 helix 3/helix 4 linker 2/helix 4
Buffer 2.75 0.7 4.5 5 1.5 5.7 5 2.2 3.65 1.0 2.75 0.7 3.85 1.3 3.5 5 1.1
40 mM SDS 3.15 0.7 5.2 5 1.5 6.6 5 2.1 3.45 0.9 3.05 1.1 4.75 1.5 3.2 5 0.9
450 mM SDS 3.15 0.7 5.2 5 1.4 7.7 5 1.8 3.45 0.8 2.95 0.8 4.85 1.3 3.2 5 0.9
40 mM LPPG 2.45 0.7 3.5 5 1.1 5.0 5 1.3 3.45 0.8 2.55 0.7 3.35 1.2 2.8 5 1.1
POPC/POPS 2.65 0.9 6.0 5 1.7 N/A 3.85 1.1 2.55 0.7 5.55 1.5 3.7 5 1.3
Here, Dr is defined as FWHM. All distances are in nanometers. N/A, not available.
1448 Georgieva et al.surface of small spheroidal micelles decreases the average
distance between them compared with the distance sampled
in the membrane-free state, but when a larger binding sur-
face is available, such as that of a cylindrical micelle or a
lipid vesicle, the helices are free to move farther away
from each other. Thus, the data support a model in which
the regions between the helices are relatively flexible, and
the helices are neither directly associated with each other
nor arranged in any specific way with respect to each other
by the intervening regions.
Under our conditions, it is expected that 40 mM SDS
solutions will form spheroidal micelles with a diameter of
~3.5 nm (70), whereas 450 mM SDS solutions will form cy-
lindrical or rod-like micelles with a considerably larger size
and surface area (27). Therefore, it was unexpected that the
distance distributions measured in 40 mM SDS were nearly
identical to those measured in 450 mM SDS, and were asso-
ciated with significantly larger interhelix distances (as well as
somewhat broader distributions) than those observed in
40 mM LPPG (which forms spheroidal micelles with a diam-
eter of ~4 nm (71)). This observation suggests that protein
molecules at both SDS concentrations are bound to rod-like
micelles. We previously found that the membrane-binding
protein a-synuclein is able to influence the topology of SDS
micelles and cause the formation of rod-like micelles at
SDS concentrations where spheroidal micelles are expected
in the absence of protein (27). Although we postulated that
this activity of synuclein may reflect a physiologically rele-
vant capacity to remodel membranes, our current data suggest
that the tau MBD may also possess the ability to remodel
detergent micelle topology. Synuclein has been reported to
bridge individual detergent micelles under certain conditions
(72), and it may be that binding of individual tauMBD helices
to different spheroidal micelles can also cluster them together
and thereby promote their fusion into cylindrical micelles.
Whether such a capacity is in any way related to tau function
or pathology remains to be investigated.DISCUSSION
Tau-membrane interactions can enhance tau aggregation
in vitro (12,13,15), consistent with a possible role for mem-Biophysical Journal 107(6) 1441–1452branes in inducing tau aggregation in vivo (21,22). Tau can
be localized to membranes indirectly via protein-protein in-
teractions with membrane-associated proteins (16–18), but
the MBD of tau also binds directly to membrane surfaces
(19,20,50,57). It is possible that protein-protein interactions
that localize tau at the membrane also promote direct mem-
brane binding by the MBD, which can then lead to tau
aggregation. Despite growing interest in tau-membrane in-
teractions, relatively little is known about the structural
changes in tau that accompany membrane binding. An anal-
ysis based on x-ray and neutron scattering measurements
indicated that tau becomes more compact upon membrane
binding before membrane-induced aggregation (15).
Detailed NMR studies of MBD fragments associated with
detergent or lysophospholipid micelles have shown that
upon binding to phospholipids or detergents, regions within
each of the repeats of the MBD adopt a highly helical struc-
ture (50,57). Interestingly, these same regions exhibit a
much weaker propensity for helical structure even in the
free state of the protein (56,57). Studies of individual tau re-
peats have shown that helical structure can also be induced
in similar regions by fluorinated alcohols, and that the
formation of helical structure promotes tau aggregation
(73–76). CD data show that the MBD also accrues helical
structure upon binding to lipid vesicles (50,57), but no
detailed structural information is available for the vesicle-
bound form of the protein. In this study, we set out to deter-
mine whether regions that become helical when the tau
MBD binds to micelles are also helical in the membrane-
bound of the protein, and to assess the relative arrangements
of any such helices on micelle and vesicle surfaces.
By applying an approach combining CW- and pulse-ESR
experiments, we were able to access and characterize at
different levels the structure of membrane-bound tau K19,
a fragment that corresponds to the MBD repeats of 3R iso-
forms of human tau protein. Our results show that helical
segments previously identified in micelle-bound tau K19
also adopt helical structure when tau K19 binds to lipid ves-
icles. This result is consistent with the weak but detectable
helical propensity of these regions in the lipid-free form
of tau (56,57), and also with the induced helicity observed
in CD spectra of membrane-bound tau MBD fragments
FIGURE 6 Schematic illustration of tau MBD-membrane interactions.
Based on our CW-ESR microwave power saturation experiments, short sur-
face-associated helices form within each MBD repeat upon membrane
binding, located at residues 253–261 (helix 1), 315–323 (helix 3), and
346–355 (helix 4). Based on our long-range DEER distance measurements,
these helices are connected by flexible linkers and the MBD can adopt
either more extended conformations in the case of more expansive mem-
brane surfaces, such as those of ~75 nm diameter liposomes (left), or
more compact conformations in the case of smaller surfaces, such as those
of ~4 nm diameter micelles (right). Although helix-to-helix distances
change considerably between vesicles and micelles, helix linker distances
are relatively unaffected.
Tau Binds Membrane via Short Helices 1449(50,57). Furthermore, we show that the helical segment
within R1 of vesicle-bound K19 is also helical in vesicle-
bound tau352, the shortest FL human tau isoform. A phase
shift of approximately one residue in the helical structure of
R1 is observed for membrane-bound tau352 relative to K19,
suggesting that the presence of protein regions outside the
MBDmay influence MBD structure in the membrane-bound
state. This is consistent with indications for long-range
structure in FL lipid-free tau (58), as well with indications
that the membrane-bound form of tau is compact (15).
Nevertheless, a very clear helical periodicity is evident for
the helical region of R1 in membrane-bound tau352, con-
firming that this region becomes helical in the context of
the FL protein as well.
We also obtained clear evidence that the helical structure
in the MBD repeats of membrane-bound tau is surface asso-
ciated and does not assume a transmembrane configuration.
Indeed, we find that the amphipathic helical structure is
largely restricted to the lipid headgroup region of the bilayer
and does not penetrate deeply into the acyl chain region of
the membrane. This is also consistent with the previous
observation that the micelle-bound MBD helices do not
penetrate deeply into the hydrophobic micelle interior
(50). As the short length of the MBD helical segments
(approximately nine residues) limits the number of hydro-
phobic side chains on the apolar side of the helix (three hy-
drophobes per helix), a shallow penetration into the acyl
chain region of the membrane is perhaps not surprising. In
addition, the lysine side chains that decorate the boundary
between the polar and apolar sides of the individual helices
would favor interactions with negatively charged lipid head-
groups, and may also act to prevent deep penetration beyond
the headgroup region.
Because amphipathic helices can often pack together into
globular folds, we investigated the relative arrangements of
the individual tau MBD helices on membrane and micelle
surfaces. Our results, based on ESR distance measurements,
clearly demonstrate that the helices within the tau MBD are
widely dispersed on the surface of lipid vesicles: neigh-
boring helices (R1-R3 and R3-R4) are separated by an
average distance of ~6 nm, whereas the distance separating
R1 from R4 is beyond the reach of the current measure-
ments. These large interhelix distances suggest that the con-
necting linker regions adopt highly extended conformations.
When combined with the observation that the width of the
distance distributions is typical of that found between sites
in highly disordered proteins, our data suggest that the indi-
vidual helices are linked by largely disordered polypeptide
segments on the membrane surface. This assertion is further
supported by the observation that when tau is confined to
smaller surfaces, such as those of cylindrical or spheroidal
micelles, the distances between the helices decrease with
the binding surface area, indicating that the linker regions
are able to adapt to different spatial constraints. Although
for the sake of simplicity only 3R versions of tau wereused in this study, there is no reason to believe that the pres-
ence of R2 would qualitatively alter the observed behavior
of the MBD in the context of lipid vesicles, given that R2
behaves similarly to the other repeats in the context of
micelles (57). Our results are summarized in a schematic
illustration in Fig. 6, which shows the location of the indi-
vidual helices within each MBD repeat, and the variation
of the interhelix distances in going from vesicles to micelles.
It is interesting to consider the potential implications of
our findings for tau function and aggregation. The induction
of helical structure upon membrane binding by disordered
amyloidogenic proteins is a somewhat common theme that
has now been observed for tau, a-synuclein, the Ab peptide,
and amylin. In the latter three cases, models have emerged
that posit that amphipathic helical structure may serve to
bring protein molecules into close contact with one another,
and in particular to cluster and align nearby amyloidogenic
nonhelical regions in a way that would facilitate the nucle-
ation of intermolecular b-sheet formation (77–79). In light
of this, it is interesting to consider that three of the four he-
lical regions of the tau MBD immediately follow a region
that has been demonstrated to effectively nucleate tau fila-
ment formation (the PHF6 and PHF6* regions in R2 and
R3) (80,81) or to potently modulate tau filament formation
(the Module B motif in R4) (82) (the helical region in R1
is an exception because it follows a segment that contains
multiple proline residues and therefore is unlikely to
nucleate b-sheet formation). Thus, it seems plausible that
also in the case of tau, membrane binding may facilitate ag-
gregation and filament formation via the clustering of mem-
brane-bound amphipathic helices, which would then bring
into close proximity and alignment highly amyloidogenic
nonhelical regions that can participate in the earliest steps
of intermolecular b-sheet formation (83).Biophysical Journal 107(6) 1441–1452
1450 Georgieva et al.With respect to normal tau function, we previously postu-
lated that the amphipathic helices formed by the MBD upon
micelle binding could also serve to mediate tau-microtubule
interactions. Independent binding of each helical segment to
a tubulin heterodimer site within the microtubule structure
would allow tau to bridge between tubulin dimers both
within the same protofilament and across different protofila-
ments. Although this hypothesis remains to be proved or
disproved, our observation that these helices also form
on membrane surfaces strengthens the argument that these
regions of the protein are disposed to form helical structure
when tau forms complexes with a variety of binding
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